Literature DB >> 19808225

Interstitial cystitis: an unsolved enigma.

Dimitrios-Anestis Moutzouris1, Matthew E Falagas.   

Abstract

Painful bladder syndrome/interstitial cystitis (PBS/IC) is a chronic disease of unknown etiology characterized by vague bladder pain and nonspecific urinary symptoms, such as urgency and frequency. Although it was initially considered to be a rare condition, its prevalence has significantly increased, possibly because of different definitions used and greater physician awareness. Because of the multiple diagnostic criteria used, there is significant variation in its prevalence. In addition, there is often a delay in the diagnosis of PBS/IC. It affects predominantly women of middle age, and it significantly decreases quality of life. Diagnosis of PBS/IC is mainly a diagnosis of exclusion; there are no characteristic symptoms or pathognomonic findings. Therefore, it is important to rule out diseases that have a similar clinical picture (i.e., urinary infections, bladder carcinoma) but definite therapies and worse prognosis if left untreated. PBS/IC management suffers from lack of evidence; many therapies are empiric or based on small studies and case series. Treatment includes supportive therapies (psychosocial, behavioral, physical), oral treatments, and intravesical treatments, whereas other more invasive treatments such as electric neuromodulation and reconstructive surgery are reserved for refractory cases. Physicians should always keep in mind the diagnosis of PBS/IC in patients presenting with chronic urinary symptoms after excluding other more common diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19808225     DOI: 10.2215/CJN.02000309

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  26 in total

1.  Integration analysis of quantitative proteomics and transcriptomics data identifies potential targets of frizzled-8 protein-related antiproliferative factor in vivo.

Authors:  Wei Yang; Yongsoo Kim; Taek-Kyun Kim; Susan K Keay; Kwang Pyo Kim; Hanno Steen; Michael R Freeman; Daehee Hwang; Jayoung Kim
Journal:  BJU Int       Date:  2012-06-28       Impact factor: 5.588

2.  Increased urothelial paracellular transport promotes cystitis.

Authors:  Nicolas Montalbetti; Anna C Rued; Dennis R Clayton; Wily G Ruiz; Sheldon I Bastacky; H Sandeep Prakasam; Amity F Eaton; F Aura Kullmann; Gerard Apodaca; Marcelo D Carattino
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-30

3.  Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.

Authors:  Tsuyoshi Majima; Pradeep Tyagi; Koji Dogishi; Mahendra Kashyap; Yasuhito Funahashi; Momokazu Gotoh; Michael B Chancellor; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2017-04-18       Impact factor: 5.695

Review 4.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

Review 5.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

Review 6.  Interventional therapies for controlling pelvic pain: what is the evidence?

Authors:  Isabel C Green; Sarah L Cohen; Dayna Finkenzeller; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2010-02

7.  Expression of nitric oxide synthase and aquaporin-3 in cyclophosphamide treated rat bladder.

Authors:  Kun Hyun Cho; Jae Ho Hyun; Young Seop Chang; Yong Gil Na; Ju Hyun Shin; Ki Hak Song
Journal:  Int Neurourol J       Date:  2010-10-31       Impact factor: 2.835

8.  Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats.

Authors:  Tsuyoshi Majima; Yasuhito Funahashi; Shun Takai; William F Goins; Momokazu Gotoh; Pradeep Tyagi; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2015-08-31       Impact factor: 5.695

Review 9.  Neurotrophins as regulators of urinary bladder function.

Authors:  Peter Ochodnicky; Célia D Cruz; Naoki Yoshimura; Francisco Cruz
Journal:  Nat Rev Urol       Date:  2012-10-09       Impact factor: 14.432

10.  Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.

Authors:  Darryl T Martin; Jill M Steinbach; Jingchun Liu; Shogo Shimizu; Hristos Z Kaimakliotis; Marcia A Wheeler; Adam B Hittelman; W Mark Saltzman; Robert M Weiss
Journal:  Mol Cancer Ther       Date:  2013-11-12       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.